China’s Patent Commercialization Bottleneck: Why 1.349 Million Dormant University Patents Matter Now

An article by CNIPA Commissioner Shen Changyu published in the 2026 Issue 6 of Qiushi puts a hard number on one of China’s longest-running innovation problems: more than 1.349 million existing patents held by universities and research institutions had not been effectively commercialized before a nationwide stocktaking and value assessment was carried out across more than 2,700 institutions. The article also sets that backlog against two powerful indicators of economic relevance. Patent-related technology contract turnover reached RMB 1.18 trillion in 2025, while the value added of China’s patent-intensive industries reached RMB 18.04 trillion in 2024, accounting for 13.38% of GDP.

The real significance of those figures is not simply that China has “many patents,” but that the next phase of IP policy is being forced to confront a more difficult question: which patents can actually move into products, supply chains, licensing programs and industrial investment. Shen identifies five recurring obstacles—patents that cannot be commercialized, are not worth commercializing, are too risky to commercialize, lack capable intermediaries, or face weak market conditions. Read together, they point to a structural diagnosis: the problem is no longer just output, but conversion.

1. The stockpile problem is really a quality-filtering problem

The headline number—1.349 million dormant patents—should not be read only as evidence of underused assets. It also reflects a transition in governance logic. For years, patent policy could be measured through filings, grants and headline totals. But once commercialization becomes the policy target, those counting metrics lose explanatory power. A university may hold a large portfolio and still have very little that is immediately licensable, investable or scalable in industry.

That is why the recent nationwide inventory matters. Its value is not merely administrative. It creates the basis for sorting patents by technical maturity, claim stability, implementation cost, substitutability and industrial fit. In practice, that means China is moving from managing patents as a statistical stock to managing them as an economic resource pool. The next competitive advantage will likely come not from owning more patents in the abstract, but from identifying higher-value bundles that can survive due diligence and match real enterprise demand.

2. “Cannot commercialize” often begins upstream, at the R&D and filing stage

One of the sharpest points in Shen’s article is that a portion of university patents were never designed with market deployment in mind. Some were generated to satisfy project completion, institutional assessment or promotion requirements rather than downstream adoption. Once that happens, the commercialization problem is effectively built into the asset from the start. Technology transfer offices then inherit patents whose legal existence is clear but whose market destination is vague.

This matters because many reform discussions still focus too heavily on the transfer stage. Yet weak conversion frequently reflects weak alignment much earlier—during project design, patent drafting and collaboration choices. If universities continue to reward patent quantity more than industrial relevance, the pipeline will keep producing assets that look impressive on paper but remain commercially thin. A more durable solution would push market-oriented review upstream, encouraging earlier enterprise participation in defining problems, co-developing solutions and shaping patent strategy around application scenarios rather than publication or filing counts alone.

3. Incentives and risk controls must be reformed together, not separately

The familiar complaint that universities “do not want to transfer” patents is only part of the story. In reality, researchers and institutions often face a lopsided equation: commercialization is slow, uncertain and labor-intensive, while the personal and organizational upside may be limited or delayed. At the same time, undervaluation concerns and state-asset loss risks can make decision-makers reluctant to approve transactions, especially where pricing is difficult and outcomes are uncertain.

That is why income distribution reform, due-diligence standards and fault-tolerance mechanisms belong in the same policy package. Without clearer revenue-sharing arrangements, researchers may remain disengaged. Without defensible valuation processes and safe-harbor style protections for compliant decision-making, institutions may continue to prefer inaction over manageable risk. In other words, “unwilling” and “afraid” are not separate categories for long; they reinforce each other unless governance and incentives move in tandem.

4. The weakest link may be professional intermediation, not patent supply alone

Many universities do not simply need more platforms; they need stronger commercialization capability around the patents they already hold. Successful transfer requires much more than posting opportunities online. It depends on claim review, legal-status checks, technology readiness assessment, industry mapping, enterprise targeting, transaction structuring, pilot validation and post-deal coordination. Where service providers lack sector knowledge or execution depth, patent transfer becomes a formal listing exercise rather than a real market process.

This is where the discussion becomes more operational. China’s next step is likely to depend on whether universities, regional platforms and service institutions can build hybrid teams that understand law, technology and industry at the same time. The difference between a visible patent database and a functioning patent market is usually not the existence of information, but the quality of interpretation, matching and transaction design around that information.

5. AI could improve matching, but it will not solve valuation and accountability by itself

Shen’s proposal to use artificial intelligence models to facilitate IP commercialization is especially notable because it responds to a real bottleneck on the demand side. Small and medium-sized enterprises often do have technical needs, but they may struggle to describe them in patent-search language, compare alternative solutions or identify relevant university portfolios. AI tools could reduce search costs by linking patent texts, industrial classifications, supply-chain data, regional industry profiles and enterprise R&D preferences.

Still, AI should be understood as an enabling layer rather than a substitute for institutional judgment. It may help discover opportunities, cluster technology options and surface likely matches, but it cannot on its own settle pricing, confirm enforceability, allocate implementation risk or replace diligence. Its success will depend on whether China can build reliable patent datasets, structured demand labels and auditable human-in-the-loop workflows. If those foundations improve, AI could help turn dormant university patents into a more responsive supply for SMEs. If not, it may simply accelerate noise.

Seen in that light, China’s current patent commercialization agenda is broader than a one-off clean-up of idle assets. It is a test of whether the country can shift from an IP system optimized for accumulation to one optimized for deployment. The answer will shape not only the fate of university patents, but also how far patent-intensive industries can continue contributing to productivity and growth.